Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $972 - $575,070
-7,484 Reduced 18.97%
31,964 $2.27 Million
Q2 2022

Aug 12, 2022

BUY
$72.62 - $79.98 $878,992 - $968,077
12,104 Added 44.27%
39,448 $3.04 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $1.68 Million - $2.02 Million
27,344 New
27,344 $2 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $971,561 - $1.13 Million
-18,116 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $15 Million - $17.6 Million
-253,920 Reduced 93.34%
18,116 $1.07 Million
Q2 2021

Aug 12, 2021

SELL
$61.91 - $67.42 $4.97 Million - $5.41 Million
-80,309 Reduced 22.79%
272,036 $18.2 Million
Q1 2021

May 12, 2021

BUY
$59.34 - $66.74 $18.2 Million - $20.4 Million
306,318 Added 665.52%
352,345 $22.2 Million
Q4 2020

Feb 11, 2021

SELL
$57.74 - $65.43 $974,247 - $1.1 Million
-16,873 Reduced 26.83%
46,027 $2.86 Million
Q3 2020

Nov 16, 2020

BUY
$57.43 - $63.64 $3.61 Million - $4 Million
62,900 New
62,900 $3.79 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.